Oxytocin in Multiparous Women
ConditionPregnancy Related
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRambam Health Care Campus
About this trial
This is a randomized controlled trial investigating whether continuous oxytocin infusion in multiparous women shortens time to delivery, without altering maternal or neonatal outcomes, in augmented deliveries, compared to intermittent infusion.
Eligibility criteria
Qualifiers
multiparous women (women who have given birth one or more times in the past) with a singleton pregnancy that are admitted for induction of labor.
Women at gestational age of 370/7 or more.
Vertex presentation.
Disqualifiers
Age 18 and under.
High order gestation.
Women with contraindication for vaginal delivery.
Previous cesarean delivery.
Trial design
Treatments tested in this trial
- Pitocin Injectable Product
Treatment groups
166 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov